We are Napo Therapeutics: an European pharmaceutical company, a young start-up led by a team of experienced professionals.
Our mission is to improve the quality of life of people suffering from rare diseases and pathologies with a strong unmet medical need through innovative solutions.
Our name reflects our story: The Napo River crosses the territories of the Amazon where the Croton lechleri tree grows – the plant from which we extract the sap that contains a precious active ingredient. We are investigating an innovative and first-in-class drug thanks to the novel mechanism of action of this active ingredient, in order to register it throughout Europe. Right now, our focus is on two serious rare diseases: short bowel syndrome (SBS) and congenital diarrheal disorders (CDD).
Napo Therapeutics is a European Company headquartered in Milan. Our majority shareholder is Napo Pharmaceuticals, a wholly owned subsidiary of Jaguar Health, which is headquartered
in San Francisco, California and listed on NASDAQ (JAGX).
Company Details
- Employees
- 9
- Founded
- -
- Address
- Via Michele Barozzi, 2, Milan,20122,italy
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://napotherapeutics.com/
- HQ
- Milan
Napo Therapeutics Questions
Napo Therapeutics's website is https://napotherapeutics.com/
Napo Therapeutics's LinkedIn profile is https://it.linkedin.com/company/napo-therapeutics
Napo Therapeutics has
9 employees.
View email and phone details for 9
employees at Napo Therapeutics.
Napo Therapeutics's industry is
Biotechnology Research
Napo Therapeutics's top competitors are
Gb Pharma,
Enterprise Therapeutics,
Biogen,
Jaguar Health,
Applied Therapeutics, Inc.,
Pietro Coricelli S.p.a.,
Rlm Consulting,
Ocugen,
Neurolieve Biosciences Ltd,
Napo Pharmaceuticals, Inc..
Napo Therapeutics's categories are Biotechnology Research
Napo Therapeutics's founding year is 2021
